Biomark Diagnostics Inc. (CSE:BUX)
Canada
· Delayed Price · Currency is CAD 0.2800
0.00 (0.00%)
May 8, 2025, 9:37 AM EDT
Biomark Diagnostics Statistics
Total Valuation
CSE:BUX has a market cap or net worth of CAD 25.91 million. The enterprise value is 27.39 million.
| Market Cap | 25.91M |
| Enterprise Value | 27.39M |
Important Dates
The next estimated earnings date is Friday, July 25, 2025.
| Earnings Date | Jul 25, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
| Current Share Class | n/a |
| Shares Outstanding | n/a |
| Shares Change (YoY) | +709.75% |
| Shares Change (QoQ) | +874.01% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | 53.71M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 167.14 |
| PB Ratio | -23.60 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -14.44 |
| EV / Sales | 167.58 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -31.87 |
Financial Position
The company has a current ratio of 0.10
| Current Ratio | 0.10 |
| Quick Ratio | 0.10 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | -1.73 |
| Interest Coverage | -27.12 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -107.55% |
| Return on Invested Capital (ROIC) | -144.93% |
| Return on Capital Employed (ROCE) | 297.51% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | 0.14 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
| Beta (5Y) | -0.52 |
| 52-Week Price Change | n/a |
| 50-Day Moving Average | 0.25 |
| 200-Day Moving Average | 0.23 |
| Relative Strength Index (RSI) | 77.32 |
| Average Volume (20 Days) | 4,351 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, CSE:BUX had revenue of CAD 155,029 and -1.90 million in losses. Loss per share was -0.00.
| Revenue | 155,029 |
| Gross Profit | 155,029 |
| Operating Income | -1.92M |
| Pretax Income | -1.90M |
| Net Income | -1.90M |
| EBITDA | -1.90M |
| EBIT | -1.92M |
| Loss Per Share | -0.00 |
Balance Sheet
The company has 88,583 in cash and 1.49 million in debt, giving a net cash position of -1.40 million.
| Cash & Cash Equivalents | 88,583 |
| Total Debt | 1.49M |
| Net Cash | -1.40M |
| Net Cash Per Share | n/a |
| Equity (Book Value) | -1.10M |
| Book Value Per Share | -0.01 |
| Working Capital | -1.36M |
Cash Flow
In the last 12 months, operating cash flow was -855,645 and capital expenditures -3,744, giving a free cash flow of -859,389.
| Operating Cash Flow | -855,645 |
| Capital Expenditures | -3,744 |
| Free Cash Flow | -859,389 |
| FCF Per Share | n/a |
Margins
| Gross Margin | 100.00% |
| Operating Margin | -1,235.35% |
| Pretax Margin | -1,223.42% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
CSE:BUX does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -709.75% |
| Shareholder Yield | -709.75% |
| Earnings Yield | -7.32% |
| FCF Yield | -3.32% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
CSE:BUX has an Altman Z-Score of -27.36. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -27.36 |
| Piotroski F-Score | n/a |